Navigation Links
Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
Date:7/1/2011

NUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state. Studies to support the effectiveness of NUEDEXTA were performed in patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). NUEDEXTA has not been shown to be safe and effective in other types of emotional lability that can commonly occur, for example, in Alzheimer's disease and other dementias. The primary outcome measure, laughing and crying episodes, was significantly lower in the NUEDEXTA arm compared to placebo. The secondary outcome measure, the Center for Neurologic Studies Lability Scale (CNS-LS), demonstrated a significantly greater mean decrease in CNS-LS score from baseline for the NUEDEXTA arm compared to placebo.

NUEDEXTA Important Safety Information

NUEDEXTA can interact with other medications causing significant changes in blood levels of those medications and/or NUEDEXTA. NUEDEXTA is contraindicated in patients receiving drugs that both prolong QT interval and are metabolized by CYP2D6 (e.g., thioridazine and pimozide) and should not be used concomitantly with other drugs containing quinidine, quinine, or mefloquine. NUEDEXTA is contraindica
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Pa. , Feb. 27, 2015  In recognition ... ongoing commitment to the global bleeding disorders community, ... 2 million international units (IUs) of protein therapies to ... international not-for- profit organization which has worked to improve ... bleeding disorders. The donation supports the WFH,s Global Alliance ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... and markets innovative proprietary products to treat voiding dysfunctions, ... Annual ROTH Conference on Tuesday, March 10, 2015. ... Reynolds , Chief Financial Officer, will present at 4:00 ... one at the conference at the Ritz Carlton in ...
(Date:2/26/2015)... 27, 2015 RnRMarketResearch.com adds ... research report to its store. This report p ... pipeline. The report "Corneal Ulcers - Pipeline Review, ... development for Corneal Ulcers. Corneal Ulcers are primarily ... infections, viral infections & fungal infections. The symptoms ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Uroplasty to Participate in the 27th Annual ROTH Conference 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... 23, 2011 The unfortunate fact in America is that ... way to the fad of weight loss. Too many people ... that accompany it are being seduced into experimenting with ineffective, ... Los Angeles . Thankfully, experts like Dr. Paya and Dr. ...
... Fine Chemicals LLC (AFC), a wholly-owned subsidiary of American ... has joined AFC as Vice President of Operations.  "We ... Terry to assume responsibility for our extensive multi-plant operations," ... Vollrath, a 30-year veteran of the active pharmaceutical ingredient ...
Cached Medicine Technology:Why the Brand Surgical Institute in L.A. is Fast Becoming the Authority on Weight Loss Surgery 2AMPAC Fine Chemicals Names Terry Vollrath Vice President of Operations 2AMPAC Fine Chemicals Names Terry Vollrath Vice President of Operations 3
(Date:2/28/2015)... 28, 2015 Dr. Perry Patel ... area residents, recently announced a special offer for the ... treatment option for new and established patients at his Pismo ... a bright, white smile, Dr. Patel and his staff ... marked down from the regular price of $450. , ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Kaylie Corrigan, ... alcohol treatment center , and current student obtaining her ... has implemented a weekly forum in psychoeducation on substance ... in Flagstaff, AZ as part of her studies. , ... need for support and counseling at the high school ...
(Date:2/28/2015)... The noted Friedman Dental Group of South Florida ... their website. The new version of the site is ... section about their team members. Potential and current patients ... each Friedman Dental Group team member including new staff. ... provide our patients with the opportunity to get to ...
(Date:2/28/2015)... WI (PRWEB) February 28, 2015 ... designation recognizes Mercy Harvard Hospital as stroke capable by ... be brought via ambulance to Mercy Harvard Hospital. , ... state to indicate their ability to treat stroke according ... designation allows ambulances transporting stroke patients to bypass hospitals ...
(Date:2/28/2015)... February 28, 2015 Memphis, TN: MedixSafe ... 2015, for a new security reader named Guardian ... reader is a new biometric scanner that significantly ... new features, the new biometric scanner provides fast ... administrators. , MedixSafe narcotics lockers with ...
Breaking Medicine News(10 mins):Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2
... today announces that its limited partnership, Mobile Diagnostic Centers has appointed ... ... LAS VEGAS (Business Wire EON) October 31, 2008 -- Mobile ... Director of Marketing and Operations in June 2008 with the original ...
... phase of childbirth can reduce health risks to themselves and ... extra two hours, according to a new study by researchers ... doing so, obstetricians could eliminate more than 130,000 cesarean deliveries ... year in the United States, the researchers conclude. , ...
... Receives Second Indication this Year; Data Demonstrate High, Durable ... Progressed ... Rituximab-Containing Regimen, FRAZER, Pa., Oct. 31 Cephalon, ... Drug Administration (FDA) has,approved TREANDA(R) (bendamustine hydrochloride) for Injection ...
... HARRISBURG, Pa., Oct. 31 November is,American Diabetes ... Pennsylvanians that there are steps they can take to ... to rise, making the disease a serious -- and,expensive ... cases of diabetes can be delayed or prevented if ...
... to be featured in the December issue of Reader,s, ... fight against breast cancer, WOODBURY, Minn., Oct. 31 ... Reader,s Digest have partnered together for the,first time to ... life,Warriors who fight the disease. Reader,s Digest asked its ...
... dedicated to providing information and support for patients, families, and ... spinal cord injury, traumatic brain injury, and amputation. , ... ... 2008 -- Catstrophicinjury.com is a new premier one-stop ...
Cached Medicine News:Health News: Mobile Imaging Innovator, Mobile Diagnostic Centers LP, Appoints New CEO : Mobile Imaging Development's Limited Partnership, Mobile Diagnostic Centers LP. Has Appointed Patrick McNamara as CEO 2Health News:Patience during stalled labor can avoid many C-sections, UCSF study shows 2Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 2Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 3Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 4Health News:Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 5Health News:Health Secretary Raises Awareness About Diabetes; Rising Costs of Treatment 2Health News:Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Reader's Digest for Exemplifying the Fight Against Breast Cancer 2Health News:Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Reader's Digest for Exemplifying the Fight Against Breast Cancer 3Health News:Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Reader's Digest for Exemplifying the Fight Against Breast Cancer 4Health News:New Online Support Site Offers Hope, Information, and Help for Patients Who Have Suffered a Catastrophic Injury 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: